Note: Ingredients listed on restricted chemical lists
EC/CAS
200-578-6/64-17-5
Name of the chemical
Ethanol
Concentration
<20
EC/CAS
201-069-1/77-92-9
Name of the chemical
Citric acid
Concentration
**
EC/CAS
500-019-9/25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
limit (SCL
EC/CAS
500-019-9/9005-65-6
Name of the chemical
polyethyleneglycol sorbitan monooleate
Concentration
*
General Information
Version
3
Revision date
2025-06-17
Product name
Docetaxel Injection, USP (Hospira, Inc.)
Product name
Docetaxel Injection, USP (Hospira, Inc.)
Identification on the label/Trade name
Taxespira Not determined
Chemical name
Not determined
1.2.1 Relevant identified uses
Antineoplastic
Icons in SDS
Company Information
company name
Pfizer New Zealand Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H319, H341, H360D, H362
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
OSHA Classification of the substance or mixture GHS - Classification. Serious eye damage/eye irritation Germ cell mutagenicity Reproductive toxicity Effects on or via lactation Category 2 - (H319) Category 2 - (H341) Category 1B - (H360D) Yes - (H362)
Physical hazards
Flammable liquids Category 2 - (H225)
2.3 Other hazards
Not applicable (HNOC) An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8). Causes mild skin irritation.
Signal word
Danger
Hazard statements
H319 - Causes serious eye irritation H341 - Suspected of causing genetic defects H360D - May damage the unborn child H362 - May cause harm to breast-fed children H225 - Highly flammable liquid and vapor
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking P280 - Wear protective gloves/protective clothing/eye protection/face protection P308 + P313 - IF exposed or concerned: Get medical advice/attention P260 - Do not breathe dust/fume/gas/mist/vapors/spray P263 - Avoid contact during pregnancy/while nursing 56 % of the mixture consists of ingredient(s) of unknown acute oral toxicity. 45 % of the mixture consists of ingredient(s) of unknown acute dermal toxicity. 82 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (dust/mist). 100 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (gas). 100 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (vapor). Unknown aquatic toxicity Contains 0 % of components with unknown hazards to the aquatic environment. Contains Docetaxel anhydrous
PBT Substances
& vPvB The product does not contain any substance(s) classified as PBT or vPvB. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Note This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
2.1 Classification of the substance or mixture
GHS - Classification. Serious eye damage/eye irritation Category 2 - (H319) Germ cell mutagenicity Category 2 - (H341) Reproductive toxicity Category 1B - (H360D) Effects on or via lactation Yes - (H362) Physical Hazards Flammable liquids Category 2 - (H225) OSHA Classification Hazards not otherwise classified (HNOC) Not applicable Hazards classified under paragraph (d)(1)(ii) of 1910.1200 Not applicable